“An Open-Label Extension of Two Phase 3 Studies Evaluating Long-Term Efficacy of FMX101 4% Minocycline Foam for the Treatment of Acne Vulgaris”. SKIN The Journal of Cutaneous Medicine 3 (November 9, 2019): S1. Accessed April 4, 2025. https://skin.dermsquared.com/skin/article/view/728.